Patients benefit from minimally invasive procedures.
LOS ANGELES – (September 23, 2014) –
Laparoscopic cholecystectomy, a minimally invasive procedure to remove the gallbladder, is one of the most common abdominal surgeries in the U.S. Yet medical centers around the country vary in their approaches to the procedure with some moving patients quickly into surgery while others wait.
New Research Executive Brings Wealth of Experience to Institute
LOS ANGELES – (August 18, 2014) – Bringing a wealth of experience in research administration, Susan D. Rubin recently joined Los Angeles Biomedical Research Institute (LA BioMed) in a newly created role of chief operating officer and general counsel.
LOS ANGELES – (August 15, 2014) – Los Angeles Biomedical Research Institute (LA BioMed) recently named six new members to its Board of Directors, expanding the board’s expertise in the law, scientific research, engineering, development, public affairs and more.
David B. Duthu, Dr. David Heber, Joan Hood Jones, Anne-Merelie Murrell, Barnet Resnick and Dan Rosenfeld have joined the board of LA BioMed, one of the nation’s leading nonprofit independent research institutes.
Investigator(s):
Kamyar Kalantar-Zadeh, MD, PhD
Kamyar Kalantar-Zadeh, the world’s foremost expert on end-stage kidney disease, has followed his research to the controversial proposition that obesity might be a patient’s best friend in the hour of greatest need.
Recent findings by Kalantar-Zadeh and some of his colleagues have landed him square in the middle of an “obesity paradox,” which is the subject of sometimes heated debate among physicians, researchers and public health officials.
Article from Wakingtimes.com
A look at the psychoactive brew that brings users a spiritual payoff for their “work”
In a greenhouse at the University of Minnesota, Dennis McKenna walks past the cacao (chocolate) and the Punica (pomegranate), and strides straight to the back corner, where the vines of the plant Banisteriopsis have twisted around each other — and nearby electrical cords — to reach the room’s rafters.
“There’s also a problem that the ‘normal’ ranges for one
laboratory may be decidedly different than they are for another
laboratory,” says Ronald Swerdloff, chief endocrinologist at Harbor
UCLA Medical Center in California and LA Biomed Inv.
Testosterone supplements promise men a butch boost of resurrected
libido, energy and mood. But there’s a better way to restore
virility
“REDUCED sex drive? Decreased energy? Unwanted mood or body changes?
Is it low testosterone?”
Kythera Biopharmaceuticals’ new drug application (NDA) for its ATX-101, a submental contouring injectable drug, has been accepted for filing by the US Food and Drug Administration (FDA).
According to Kythera Biopharmaceuticals, the ATX-101 NDA will be subject to a standard review and will have a prescription drug user fee act (PDUFA) action date of 13 May 2015. The company submitted the NDA in May 2014.
The FDA’s Division of Dermatology and Dental Products is also planning to hold an Advisory Committee meeting on the company’s ATX-101 application during the review.
Investigator(s):
The Lundquist Institute
Managing diabetes is a year-round challenge for anyone living with the disease. The challenge is even greater for underserved and uninsured people who often don’t have easy access to the care they need to manage their diabetes.
Their inability to effectively manage their diabetes puts them at significantly higher risk for long-term complications, including kidney failure, amputations and blindness.
Clarus Therapeutics, Inc., a men’s health specialty pharmaceutical company focused on the development and commercialization of REXTORO ( (Testosterone Undecanoate), an oral testosterone (T) replacement product, today presented Phase 3 clinical data from two studies that support the safety and efficacy of REXTORO for T-replacement therapy in men with hypogonadism. These results are being presented from 1-3 p.m.
Biocom, the association for the Southern California life science community, and the San Diego International Airport Art Program announce the return of the cell culture exhibit, a showcase of art from microscopic research contributing to life-changing breakthroughs taking place in the Southern California region.